Ethic Inc. Viatris Inc Transaction History

Ethic Inc.

$3.97 Billion
Q3 2024

A detailed history of Ethic Inc. transactions in Viatris Inc stock. As of the latest transaction made, Ethic Inc. holds 47,621 shares of VTRS stock, worth $589,547. This represents 0.01% of its overall portfolio holdings.

Number of Shares

47,621

Previous 73,960 35.61%

Holding current value

$589,547

Previous $786,000 29.77%

% of portfolio

0.01%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$10.32 - $12.13 $271,818 - $319,492	-26,339 Reduced 35.61%	47,621 $552,000
Q2 2024 Aug 13, 2024	BUY	$10.05 - $12.02 $264,706 - $316,594	26,339 Added 55.31%	73,960 $786,000
Q1 2024 May 13, 2024	BUY	$11.27 - $13.53 $53,442 - $64,159	4,742 Added 11.06%	47,621 $568,000
Q4 2023 Feb 14, 2024	BUY	$8.77 - $10.85 $6,919 - $8,560	789 Added 1.87%	42,879 $464,000
Q3 2023 Nov 14, 2023	SELL	$9.59 - $11.35 $27,312 - $32,324	-2,848 Reduced 6.34%	42,090 $415,000
Q2 2023 Aug 14, 2023	SELL	$9.02 - $10.29 $130,726 - $149,132	-14,493 Reduced 24.39%	44,938 $448,000
Q1 2023 May 12, 2023	SELL	$9.2 - $12.26 $99,277 - $132,297	-10,791 Reduced 15.37%	59,431 $571,000
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $355,444 - $471,208	40,762 Added 138.36%	70,222 $781,000
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $149,519 - $196,244	17,632 Added 149.07%	29,460 $251,000
Q2 2022 Aug 10, 2022	BUY	$9.95 - $12.27 $117,688 - $145,129	11,828 New	11,828 $124,000
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $154,340 - $187,404	-12,766 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.25 - $15.13 $169,149 - $193,149	12,766 New	12,766 $173,000

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

933M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account